TYME

Tyme Technologies, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.31

+0.02 (+8.07%)

CEO

Steven E. Hoffman

IPO Date

2012-05-25

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Open

$0.29

Prev. Close

$0.29

Day Low

$0.28

Day High

$0.32

Volume

2.68M

News SentimentNeutral

Articles

Avg Positive

16.2%

Avg Negative

15.1%

Avg Neutral

68.8%

News Feed

Tyme Technologies Stock Rallies: A Technical Analysis

TYME Stock: The Cancer Treatment News That's Boosting Tyme Today

Tyme Granted U.S. Patent Claims Covering Use of Tyrosine-Based Drug Delivery Method to Treat Cancer